Incidence and prevalence of multiple sclerosis in the UK 1990-2010: A descriptive study in the General Practice Research Database

Journal of Neurology, Neurosurgery and Psychiatry

Volumn 85, Issue 1, 2014, Pages 79-84

  Mackenzie, Isla S ^a   Morant, S V ^a   Bloomfield, G A ^b   MacDonald, T M ^a   O'Riordan, J ^c  

^a UNIVERSITY OF DUNDEE   (United Kingdom)

^b Multiple Sclerosis National Therapy Centres   (United Kingdom)

^c UNIVERSITY OF DUNDEE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; FACTUAL DATABASE; FALSE POSITIVE RESULT; FEMALE; GEOGRAPHIC DISTRIBUTION; HUMAN; INCIDENCE; LATITUDE; LIFE EXPECTANCY; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MORTALITY; MULTIPLE SCLEROSIS; POPULATION RESEARCH; PREVALENCE; PRIORITY JOURNAL; RESOURCE ALLOCATION; RISK REDUCTION; SEX RATIO; TREND STUDY; UNITED KINGDOM; VERY ELDERLY; YOUNG ADULT; AGE; EPIDEMIOLOGY; FOLLOW UP; GENERAL PRACTICE; GEOGRAPHY; HOSPITALIZATION; LONGITUDINAL STUDY; POPULATION; SEX DIFFERENCE; STATISTICS; TREATMENT OUTCOME; STATISTICS AND NUMERICAL DATA;

EPIDEMIOLOGY; MULTIPLE SCLEROSIS;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; DATABASES, FACTUAL; FEMALE; FOLLOW-UP STUDIES; GENERAL PRACTICE; GEOGRAPHY; GREAT BRITAIN; HOSPITALIZATION; HUMANS; INCIDENCE; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; POPULATION; PREVALENCE; SEX FACTORS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84891833705     PISSN: 00223050     EISSN: 1468330X     Source Type: Journal    
DOI: 10.1136/jnnp-2013-305450     Document Type: Article

References (31)

1. McCrone P, Heslin M, Knapp M, et al. Multiple sclerosis in the UK Service use, costs, quality of life and disability. Pharmacoeconomics 2008;26: 847-60.
2. Kobelt G, Berg J, Lindgren P, et al., Costs and quality of life of multiple sclerosis in the United Kingdom. Eur J Health Econ. 2006;7(Suppl 2):S96-104.
3. Swingler RJ, Compston D. The distribution of multiple sclerosis in the United Kingdom. J Neurol Neurosurg Psychiatry 1986;49: 1115-24. (Pubitemid 16028692)
4. Williams ES, Jones DR, McKeran RO. Mortality rates from multiple sclerosis: geographical and temporal variations revisited. J Neurol Neurosurg Psychiatry 1991;54: 104-9.
5. Forbes RB, Swingler RJ. Estimating the prevalence of multiple sclerosis in the United Kingdom by using capture-recapture methodology. Am J Epidemiol 1999;149: 1016-24. (Pubitemid 29246866)
6. Alonso A, Jick SS, Olek MJ, et al. Incidence of multiple sclerosis in the United Kingdom: findings from a population-based cohort. J Neurol 2007;254: 1736-41.
7. ISD Scotland. Scottish Multiple Sclerosis Register. http://www. isdscotland.org/ Health-Topics/Quality-Improvement/The-MS-Register (accessed 29 Jan 2013).
8. Walley T, Mantgani A. The UK General Practice Research Database. Lancet 1997;350: 1097-9. (Pubitemid 27437871)
9. Office for National Statistics. Population estimates for UK, England and Wales, Scotland and Northern Ireland, Population Estimates Timeseries 1971 to Current Year. http://www.ons.gov.uk/ons/rel/pop-estimate/population-estimates- for-uk - england-and-wales - scotland-and-northern-ireland/population- estimatestimeseries- 1971-to-current-year/index.html (accessed 27 Nov 2012).
10. Office for National Statistics. Death registrations summary tables, England and Wales, 2010. http://www.ons.gov.uk/ons/publications/re-reference- tables.html? edition=tcm%3A77-227638 (accessed 24 June 2013).
11. Runmarker B, Andersen O. Pregnancy is associated with a lower risk of onset and a better prognosis in multiple sclerosis. Brain 1995;118: 253-61.
12. Herrett E, Thomas SL, Schoonen WM, et al. Validation and validity of diagnoses in the General Practice Research Database: a systematic review. BJCP 2010;69: 4-14.
13. Thomas SL, Williams R, Williams T, et al. Estimating the prevalence of multiple sclerosis in the United Kingdom. June 2009. http://www.mssociety.org. uk/ ms-resources/ms-society-briefing-uk-prevalence-study
14. Alonso A, Hernán MA. Temporal trends in the incidence of multiple sclerosis: a systematic review. Neurology 2008;71: 129-35.
15. Koch-Henriksen N, Sorensen PS. The changing demographic pattern of multiple sclerosis epidemiology. Lancet Neurol 2010;9: 520-32.
16. Trojano M, Lucchese G, Graziano G, et al. Geographical variations in sex ratio trends over time in multiple sclerosis. PLOS one 2012;7:1-9. e48078.
17. Boström I, Stawiarz L, Landtblom AM. Sex ratio of multiple sclerosis in the National Swedish MS register. Multiple Sclerosis 2013;19: 46-52.
18. Simpson S Jr, Blizzard L, Otahal P, et al. Latitude is significantly associated with the prevalence of multiple sclerosis: a meta-analysis. J Neurol Neurosurg Psychiatry 2011;82: 1132-41.
19. Ramagopalan SV, Hoang U, Seagroatt V, et al. Geography of hospital admissions for multiple sclerosis in England and comparison with the geography of hospital admissions for infectious mononucleosis: a descriptive study. J Neurol Neurosurg Psychiatry. 2011;82: 682-7.
20. Sutherland JM. Observations on the prevalence of multiple sclerosis in Northern Scotland. Brain 1956;76: 635-54.
21. Acheson ED, Bachrach CA, Wright FM. Some comments on the relationship of the distribution of multiple sclerosis to latitude, solar radiation and other variables. Acta Psychiat (Scand) 1960;35: 132-47.
22. Poskanzer DC, Walker AM, Yonkondy J, et al. Studies in the epidemiology of multiple sclerosis in the Orkney and Shetland Islands. Neurology 1976;26: 14-17.
23. Dean G, Kurtzke JF. On the risk of multiple sclerosis according to age at immigration to South Africa. BMJ 1971;3: 725-9.
24. Van der Mei IA, Ponsonby AL, Dwyer T, et al. Past exposure to sun, skin phenotype, and risk of multiple sclerosis: case-control study. BMJ 2003;327:316.
25. Lonergan R, Kinsella K, Fitzpatrick P, et al. Multiple sclerosis prevalence in Ireland: relationship to vitamin D status and HLA genotype. J Neurol Neurosurg Psychiatry. 2011;82: 317-22.
26. Forbes RB, Wilson SV, Swingler RJ. The prevalence of multiple sclerosis in Tayside, Scotland: do latitudinal gradients really exist? J Neurol 1999;246: 1033-40.
27. Handel AE, Handunnethi L, Giovannnoni G, et al. Genetic and environmental factors and the distribution of multiple sclerosis in Europe. Eur J Neurol 2010;17: 1210-14.
28. Willer CJ, Dyment DA, Sadovnick AD, et al. Timing of birth and risk of multiple sclerosis: population based study. BMJ 2005;330:120.
29. Dobson R, Giovannoni G, Ramagopalan S. The month of birth effect in multiple sclerosis: systematic review, meta-analysis and effect of latitude. J Neurol Neurosurg Psychiatry 2013;84: 427-32.
30. Cantorna MT, Hayes CE, DeLuca HF. 1,25-Dihydroxyvitamin D3 reversibly blocks the progression of relapsing encephalomyelitis, a model of multiple sclerosis. Proc Natl Acad Sci USA 1996;93: 7861-4. (Pubitemid 26277129)
31. Ramagopalan SV, Dyment DA, Cader MZ, et al. Rare variants in the CYP27B1 gene associated with multiple sclerosis. Ann Neurol 2011;70: 881-6.